BCSVX | ISCIX | BCSVX / ISCIX | |
Total Expense Ratio | 1.31 | 0.99 | 132% |
Annual Report Gross Expense Ratio | 1.31 | 1.30 | 101% |
Fund Existence | 10 years | 17 years | - |
Gain YTD | 8.539 | 30.207 | 28% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000 | 1000000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.28B | 373M | 610% |
Annual Yield % from dividends | 0.00 | 1.51 | - |
Returns for 1 year | 11.28 | 27.10 | 42% |
Returns for 3 years | 48.21 | 68.45 | 70% |
Returns for 5 years | 25.19 | 37.60 | 67% |
Returns for 10 years | N/A | 41.73 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ACWZX | 19.34 | 0.15 | +0.78% |
AMG GW&K Small/Mid Cap Growth Z | |||
TGCNX | 25.55 | 0.01 | +0.04% |
TCW Concentrated Large Cap Growth N Cl | |||
TNBRX | 20.51 | -0.04 | -0.17% |
1290 SmartBeta Equity R | |||
LAVYX | 16.81 | -0.05 | -0.30% |
Lord Abbett Fundamental Equity I | |||
JVAQX | 40.54 | -0.13 | -0.32% |
JPMorgan Value Advantage R4 |